Literature DB >> 26088731

Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer.

Maxine Sun1, Firas Abdollah2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26088731     DOI： 10.1016/j.eururo.2015.03.054

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients.

Authors:  Patrick Terrematte; Dhiego Souto Andrade; Josivan Justino; Beatriz Stransky; Daniel Sabino A de Araújo; Adrião D Dória Neto
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

Review 2.  RNA splicing and splicing regulator changes in prostate cancer pathology.

Authors:  Jennifer Munkley; Karen Livermore; Prabhakar Rajan; David J Elliott
Journal:  Hum Genet       Date:  2017-04-05       Impact factor: 4.132

Review 3.  Advancement and properties of circular RNAs in prostate cancer: An emerging and compelling frontier for discovering.

Authors:  Hong Zhou; Xu-Dong Zheng; Chang-Ming Lin; Jie Min; Shuang Hu; Ying Hu; Liang-Yun Li; Jia-Si Chen; Yu-Min Liu; Hao-Dong Li; Xiao-Ming Meng; Jun Li; Ya-Ru Yang; Tao Xu
Journal:  Int J Biol Sci       Date:  2021-01-19       Impact factor: 6.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.